FindTrial
Sign In

Use of an Injectable Complex of Beta-Phosphate Granules, Hyaluronate, and Fibroblast Growth Factor-2 on Repair of Fracture with Bone Defects.

Use of an Injectable Complex of Beta-Phosphate Granules, Hyaluronate, and Fibroblast Growth Factor-2 on Repair of Fracture with Bone Defects. - Use of an Injectable Complex of Beta-TCP, Hyaluronate, and FGF-2 on Repair of Fracture with Bone Defects.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023208
Enrollment
20
Registered
2016-07-19
Start date
2016-03-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture with Bone Defects

Interventions

A complex of beta-TCP granules, hyaluronate, and rhFGF-2 in a cylinder is injected through the tip of the great trochanter to the base of the lesser trochanter during surgery under fluoroscopy in oper

Sponsors

Department of Orthopedic Surgery, Jikei University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: And adaptation of the fracture cases with bone defect in the 20 years of age or older.

Exclusion criteria

Exclusion criteria: The following will be the key exclusion criteria. Children Malignant tumor present example There is a history of allergy to beta-TCP, hyaluronic acid, and FGF-2 After more than four weeks after the injury open fracture

Design outcomes

Primary

MeasureTime frame
X-ray and CT Evaluation of Bone Union—

Countries

Japan

Contacts

Public ContactEiji Kijima

Department of Orthopedic Surgery, Jikei University School of Medicine Department of Orthopedic Surgery

kijijma@jikei.ac.jp03-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026